• Thumbnail for Regeneron Pharmaceuticals
    Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally...
    26 KB (2,290 words) - 23:04, 12 September 2024
  • Thumbnail for Regeneron Science Talent Search
    outbid several other companies. In May 2016, it was announced that Regeneron Pharmaceuticals would be the new title sponsor. Over the years, some 147,000 students...
    48 KB (1,256 words) - 22:09, 5 November 2024
  • Thumbnail for Dupilumab
    type of white blood cell called eosinophils. It was developed by Regeneron Pharmaceuticals and Sanofi Genzyme. It received approval from the US Food and...
    23 KB (1,813 words) - 18:30, 5 November 2024
  • Thumbnail for George Yancopoulos
    is the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals. Yancopoulos is a member of the National Academy of Sciences,...
    29 KB (3,013 words) - 19:17, 5 November 2024
  • Thumbnail for International Science and Engineering Fair
    Society for Science) and was sponsored by Intel from 1997 to 2019. Regeneron Pharmaceuticals became the title sponsor for ISEF in 2020, but the event was cancelled...
    33 KB (2,932 words) - 18:11, 2 October 2024
  • Thumbnail for Nasdaq-100
    Discovery Communications, Equinix, Liberty Global, Liberty Media, Regeneron Pharmaceuticals, SBA Communications, Verisk Analytics and Western Digital. The...
    58 KB (5,024 words) - 12:56, 5 November 2024
  • the co-founder and chief executive of the biotechnology company Regeneron Pharmaceuticals. He was born and raised in a Jewish family, the son of Florence...
    10 KB (931 words) - 20:14, 6 July 2024
  • Results - Earnings Call Transcript". "Shanghai Pharmaceuticals 2023 Annual Report" (PDF). "Shanghai Pharmaceuticals 2022 Annual Results Announcement" (PDF)....
    62 KB (2,735 words) - 16:33, 29 August 2024
  • Sanofi (category Pharmaceutical companies established in 1973)
    entered into a collaboration with Regeneron Pharmaceuticals, a New York biotechnology company, to develop Regeneron's VEGF-inhibiting drug, aflibercept...
    92 KB (8,873 words) - 14:00, 4 November 2024
  • Thumbnail for Casirivimab/imdevimab
    product. It was developed by the American biotechnology company Regeneron Pharmaceuticals. The most common side effects include allergic reactions, which...
    49 KB (3,417 words) - 04:55, 2 November 2024
  • Thumbnail for Martin Shkreli
    Berkowitz and Company, he recommended short-selling the stock of Regeneron Pharmaceuticals, a biotech company testing a weight-loss drug. When its price...
    123 KB (10,350 words) - 10:40, 6 November 2024
  • degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals. It is an inhibitor of vascular endothelial growth factor (VEGF)...
    34 KB (2,404 words) - 18:19, 5 October 2024
  • Biotechnology Ohr Pharmaceuticals Oligomerix Ovid Therapeutics Progyny Prophetic PsychoGenics Q BioMed Relmada Therapeutics Regeneron Pharmaceuticals RGenix S1...
    20 KB (1,295 words) - 22:15, 2 November 2024
  • "• Top biotech and pharmaceutical companies market value 2015 - Statistic". Statista. "ALNY Stock Price | Alnylam Pharmaceuticals Inc. Stock Quote (U...
    17 KB (174 words) - 23:52, 2 June 2024
  • 500; ..." (PDF). us.spindices.com. 2013-05-03. Retrieved 2013-05-09. "Regeneron Set to Join S&P 500; ..." www.standardandpoors.com. 2013-04-24. Retrieved...
    196 KB (6,321 words) - 16:53, 2 November 2024
  • Thumbnail for Westchester County, New York
    multinational corporations including IBM, Mastercard, PepsiCo, and Regeneron Pharmaceuticals. Westchester County high school students often feature prominently...
    84 KB (8,141 words) - 00:01, 19 October 2024
  • family Leonard Schleifer (1953–), founder of biotechnology company Regeneron Pharmaceuticals Cheryl Shuman, founder of the Beverly Hills Cannabis Club Daniel...
    110 KB (8,712 words) - 00:20, 25 September 2024
  • Thumbnail for Suffern, New York
    which was demolished for site parking. In 2023, Avon sold to Regeneron Pharmaceuticals to be used for Research & Development Laboratories In 1916, what...
    30 KB (3,079 words) - 21:54, 9 October 2024
  • Thumbnail for Rockwood Hall
    IBM's property was later bought by New York Life, followed by Regeneron Pharmaceuticals, the current owner. The remaining property was sold to New York...
    43 KB (5,163 words) - 13:50, 30 August 2024
  • was developed by Regeneron Pharmaceuticals, Inc. World Health Organization (2015). "International Nonproprietary Names for Pharmaceutical Substances (INN)...
    2 KB (69 words) - 00:30, 15 June 2023
  • target set off a race among pharmaceutical and biotech companies. Alirocumab was discovered by Regeneron Pharmaceuticals using its "VelocImmune" mouse...
    24 KB (2,254 words) - 05:22, 7 April 2024
  • and Regeneron Halt Cervical Cancer Trial Early Due to Dazzling Results, Plan to Submit to Regulators Biospace 15 March 2021 Regeneron Pharmaceuticals (11...
    13 KB (1,060 words) - 00:29, 30 September 2024
  • priority review designations. The FDA granted approval of Evkeeza to Regeneron Pharmaceuticals, Inc. In April 2021, the Committee for Medicinal Products for...
    11 KB (683 words) - 05:41, 3 March 2024
  • Thumbnail for Kenneth C. Griffin
    a possible conflict of interest when DeSantis began promoting Regeneron Pharmaceuticals' therapeutic treatment for COVID-19. DeSantis has encouraged such...
    134 KB (10,235 words) - 00:47, 5 November 2024
  • Atoltivimab/maftivimab/odesivimab (category Regeneron Pharmaceuticals)
    atoltivimab, maftivimab, and odesivimab-ebgn and was developed by Regeneron Pharmaceuticals. The most common side effects include fever, chills, tachycardia...
    20 KB (1,712 words) - 21:09, 26 January 2024
  • Thumbnail for Takeda Pharmaceutical Company
    the U.S. pharmaceutical market by developing a joint venture with Abbott Laboratories called TAP Pharmaceuticals. Through TAP Pharmaceuticals Takeda and...
    33 KB (2,778 words) - 01:29, 7 September 2024
  • 2015. Results of the FOURIER trial were published in March 2017. Regeneron Pharmaceuticals and Amgen had each filed for patent protection on their monoclonal...
    17 KB (1,472 words) - 10:46, 21 September 2024
  • (AKA AZD1222). The cells are filtered out of the final products. Regeneron Pharmaceuticals, the maker of REGN-COV2, a therapeutic antibody cocktail used...
    25 KB (3,066 words) - 02:55, 11 July 2024
  • experiments. The software is used in pharmaceutical development by companies such as Eli Lilly and Regeneron Pharmaceuticals. JMP Clinical and JMP Genomics...
    34 KB (3,262 words) - 20:40, 10 October 2024
  • This drug was developed in collaboration by Teva Pharmaceutical Industries and Regeneron Pharmaceuticals. It is currently at Phase III trials (NCT03245008...
    2 KB (142 words) - 14:19, 26 September 2023